Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Description complète

Détails bibliographiques

Auteurs principaux:	Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2023-07-01
Collection:	Frontiers in Immunology
Sujets:	multiple sclerosis cladribine biomarkers omics bioinformatics
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!